Organised by Sanofi
Chair(s)
Dr Luigi Fernando Meneghini, M.D., M.B.A. Global Medical External Expert Lead T1D Sanofi, USA
Introduction:
Type 1 diabetes needs different kind of screening techniques and the approaches to the management when compared to type 2 diabetes, and this is due to the autoimmune-mediated aetiology of T1D. T1D care include interprofessional collaborations in which pharmacist role is critical. Pharmacists, in general, actively involves in.
Programme:
| 13:30 – 13:35 | Welcome and introduction: Advancements in T1D screening and early detection | |
| Dr Luigi Meneghini, M.D., M.B.A. Global Medical External Expert Lead T1D Sanofi | |
| 13:35 – 13:55 | Recognising the unseen: T1D progression, diagnostic challenges, and evolving approaches to management |
| Dr Luigi Meneghini, M.D., M.B.A. Global Medical External Expert Lead T1D Sanofi | |
| 13:55 – 14:15 | Pharmacists: Interprofessional collaboration and leadership in T1D care |
| Dr Astrid Czock, FPH Community pharmacy, MSc Infectious Diseases, Switzerland | |
| 14:15 – 14:30 | Q&A and closing remarks |
Explaining Type 1 Diabetes: pathophysiology, progression, and different stages and related challenges.
2. Understand the pharmacist’s role in early detection of T1D. Explore practical strategies for identifying at-risk patients and supporting early diagnosis in community pharmacy settings.
Take home messages:
This symposium underscores the importance of population-wide screening for T1D as 90% of the individuals who are diagnosed do not have family history, along with people who are at risk. Misdiagnosis of T1D with T2D is common and pharmacists plays a critical role in creating awareness about the screening/diagnosis. Pharmacists work as part of an integrated care team provide independent scientific information to other healthcare workers and design individualized diabetes management plans together with the care team and patient.
